Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

February 4, 2017

Chicago, Illinois
Sheraton Grand Chicago

Scientific Agenda

 

Saturday, February 4, 2017
 

7:00 am

Registration and Continental Breakfast

8:00 am

Welcome and ARS Pre-Assessment
Kathy S. Albain, MD, FACP, FASCO

8:10 am

New Directions in Translational Research
Suzanne A.W. Fuqua, PhD

8:40 am

Novel Therapeutics:  CDK Inhibitors, Immunotherapy, and Role of Tumor Infiltrating Lymphocytes
Hope S. Rugo, MD

9:10 am

Novel Therapeutics:  HER2+ and Triple Negative Disease; New Pathways, Targets
Debu Tripathy, MD

9:40 am

Panel Q & A

9:55 am

Break

10:20 am

Adjuvant/Neoadjuvant Therapy Updates and Molecular Predictors of Benefit
Kathy S. Albain, MD, FACP, FASCO

10:50 am

Advances in Local-Regional Approaches
Constantine Godellas, MD, FACS

11:20 am

Panel Q & A

11:30 am

New Insights in Prevention, Survivorship and Health Care Delivery
Dawn L. Hershman, MD, MS

12:00 pm

Q & A

12:10 pm

A Look Back at 2016 and Challenges Ahead
Eric P. Winer, MD

12:40 pm

Q & A

12:50 pm

Closing Remarks and ARS Post-Assessment
Kathy S. Albain, MD, FACP, FASCO